TLDR:
- Germany-based Innocent Meat secures €3M in funding to enable meat processors to produce cultured meat in-house.
- Funding will support development of biocomponents, scale-up of pilot plant, and certification processes.
Germany-based startup, Innocent Meat, has raised €3M in funding to facilitate the production of cultured meat directly in-house for meat processors. The financing round included investments from Venture Capital Fonds MV and a new private investor. This funding will be used to support the development of biocomponents, scale-up of the pilot plant, and initiation of certification processes. Innocent Meat aims to democratise cultured meat production, allowing any company to enter this market. The company’s goal is to achieve price parity with traditional meat products through technological advancements and cost-efficient methods.
Founded in 2020 by Laura Gertenbach and Patrick Nonnenmache, Innocent Meat is working towards a comprehensive solution for cultured meat production through an end-to-end automated system. The company has already secured over €1M in funding and is collaborating with the University of Rostock to establish a production platform for recombinant proteins. One of the notable advancements made by Innocent Meat is the development of an FBS-free proliferation medium for porcine primary cells, replacing the traditionally used Fetal Bovine Serum (FBS) with growth factors from molecular farming techniques. This marks a significant step towards sustainable cultured pork production without the need for large-scale breeding and slaughter.
Overall, Innocent Meat’s recent funding round will support the company in further advancing their technology and processes to enable meat processors to transition to cell-based meat production with ease.
